These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 35831189)

  • 1. [Pathophysiology of hematological malignancies associated with ASXL1 mutations].
    Fujino T
    Rinsho Ketsueki; 2022; 63(6):561-572. PubMed ID: 35831189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms.
    Asada S; Kitamura T
    Int J Hematol; 2019 Aug; 110(2):179-186. PubMed ID: 30515738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of ASXL1 mutation in myeloid malignancies].
    Sheng MY; Zhou Y; Xu MJ; Yang FC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1183-7. PubMed ID: 25130853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASXL1 mutation in clonal hematopoiesis.
    Fujino T; Kitamura T
    Exp Hematol; 2020 Mar; 83():74-84. PubMed ID: 31945396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation by ASXL1 in myeloid malignancies.
    Yang FC; Agosto-Peña J
    Int J Hematol; 2023 Jun; 117(6):791-806. PubMed ID: 37062051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ASXL1-G643W variant accelerates the development of CEBPA mutant acute myeloid leukemia.
    D'Altri T; Wilhelmson AS; Schuster MB; Wenzel A; Kalvisa A; Pundhir S; Meldgaard Hansen A; Porse BT
    Haematologica; 2021 Apr; 106(4):1000-1007. PubMed ID: 32381577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of ASXL1 in hematopoiesis and myeloid malignancies.
    Asada S; Fujino T; Goyama S; Kitamura T
    Cell Mol Life Sci; 2019 Jul; 76(13):2511-2523. PubMed ID: 30927018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases.
    Gelsi-Boyer V; Brecqueville M; Devillier R; Murati A; Mozziconacci MJ; Birnbaum D
    J Hematol Oncol; 2012 Mar; 5():12. PubMed ID: 22436456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal hematopoiesis and hematological malignancy.
    Dunn WG; McLoughlin MA; Vassiliou GS
    J Clin Invest; 2024 Oct; 134(19):. PubMed ID: 39352393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ASXL1 in hematopoiesis and myeloid diseases.
    Gao X; You X; Droin N; Banaszak LG; Churpek J; Padron E; Geissler K; Solary E; Patnaik MM; Zhang J
    Exp Hematol; 2022 Nov; 115():14-19. PubMed ID: 36183966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies.
    Ye B; Sheng Y; Zhang M; Hu Y; Huang H
    Cancer Lett; 2022 Jul; 538():215691. PubMed ID: 35469959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype.
    Prats-Martín C; Burillo-Sanz S; Morales-Camacho RM; Pérez-López O; Suito M; Vargas MT; Caballero-Velázquez T; Carrillo-Cruz E; González J; Bernal R; Pérez-Simón JA
    Cancer Med; 2020 Jun; 9(11):3637-3646. PubMed ID: 32216059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)?
    Steensma DP
    Best Pract Res Clin Haematol; 2021 Dec; 34(4):101327. PubMed ID: 34865699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clonal haematopoiesis: A concise review].
    Danlos FX; Papo M; Micol JB
    Rev Med Interne; 2019 Oct; 40(10):684-692. PubMed ID: 31126662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal hematopoiesis and preleukemia-Genetics, biology, and clinical implications.
    Hartmann L; Metzeler KH
    Genes Chromosomes Cancer; 2019 Dec; 58(12):828-838. PubMed ID: 30939217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal hematopoiesis in acquired aplastic anemia.
    Ogawa S
    Blood; 2016 Jul; 128(3):337-47. PubMed ID: 27121470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of ASXL1 mutations in patients with myelodysplastic syndromes and acute myeloid leukemia: A meta-analysis.
    Zhang A; Wang S; Ren Q; Wang Y; Jiang Z
    Asia Pac J Clin Oncol; 2023 Oct; 19(5):e183-e194. PubMed ID: 36471477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal Hematopoiesis and risk of Acute Myeloid Leukemia.
    Desai P; Hassane D; Roboz GJ
    Best Pract Res Clin Haematol; 2019 Jun; 32(2):177-185. PubMed ID: 31203999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Truncation mutants of ASXL1 observed in myeloid malignancies are expressed at detectable protein levels.
    Inoue D; Matsumoto M; Nagase R; Saika M; Fujino T; Nakayama KI; Kitamura T
    Exp Hematol; 2016 Mar; 44(3):172-6.e1. PubMed ID: 26700326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies.
    Stengel A; Baer C; Walter W; Meggendorfer M; Kern W; Haferlach T; Haferlach C
    Blood Adv; 2021 Nov; 5(21):4426-4434. PubMed ID: 34570179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.